Table 2 Primer sequences
Gene | Accession number | Forward primer | Reverse primer |
|---|---|---|---|
5-HT B receptor | NM_017250 | 5′-ACAAAACATGGAATTCGAAATGG-3′ | 5′-TGGTTGAACTTCGGAGCCTTA-3′ |
Adrenergic receptor kinase, β 1 | NM_012776 | 5′-CGAGGTGGCAAGCAGTTTGT-3′ | 5′-GCAGCTCTTTTTTCCATTGCA-3′ |
Adrenergic receptor kinase, β 2 | NM_012897 | 5′-GCCCCCAAGTTCCTCAACA-3′ | 5′-CAGCGGTGGCTTGGAGAA-3′ |
Adrenergic receptor, α 1a | NM_017191 | 5′-AGTCTGTGAATGGAAGTTTTTCTCTTC-3′ | 5′-ATTGGTCCTTTGGCACTGTAATC-3′ |
Adrenergic receptor, α1b | NM_016991 | 5′-ACTTTTAGGGTCCCTTTTCATCCT-3′ | 5′-GCCCCTACGATGGTGTTCTC-3′ |
Adrenergic receptor, α 1d | NM_024483 | 5′-CCATCCGGCAAGTTTTGGT-3′ | 5′-CAGAGCGGAAGAGCAACAGAT-3′ |
Adrenergic receptor, α 2a | NM_012739 | 5′-GGTGGTGATCGGCGTGTT-3′ | 5′-CGACCGCTATGAGCGTGTAG-3′ |
Adrenergic receptor, α 2b | NM_138505 | 5′-CAGGACCACCCGGTGGTA-3′ | 5′-AAGTGGGCCCCAGAGAAATG-3′ |
Adrenergic receptor, α 2c | NM_138506 | 5′-CTGCCAGAACCGCTCTTTAAGT-3′ | 5′-CCGGGTTGAGCGAACTGT-3′ |
Adrenergic receptor, β 1 | NM_012701 | 5′-TTCGTGTACCTCCGGGTGTT-3′ | 5′-CGCTCGCAGCTGTCGAT-3′ |
Adrenergic receptor, β 2 | NM_012492 | 5′-GGACCTTTCTGCTGTGAATGTG-3′ | 5′-CCTCAAATCCCTGCCTACAACA-3′ |
Adrenergic receptor, β 3 | NM_013108 | 5′-CGTTGTCTAGGATCCACCTTGAA-3′ | 5′-GCACGGGTGGCCTGATATC-3′ |
Angiotensin 1-converting enzyme 1 | NM_012544 | 5′-GGAGTACACCTGGACACCAAACA-3′ | 5′-GAAGTTGACGCGACTGGACTCT-3′ |
Angiotensin II receptor-associated protein | NM_001007654 | 5′-GCCGCAGGTAAAGGAGTCTTC-3′ | 5′-TTTCGCAAGTCGGTTCCAA-3′ |
Angiotensin II receptor, type 1 | NM_030985 | 5′-CAGGAGCTGGATGGATTGGT-3′ | 5′-GGGAGACTGATGAGATTGCATTT-3′ |
Angiotensin II receptor, type 2 | NM_012494 | 5′-TTGTGTTGGCATTCATCATTTG-3′ | 5′-ATACCCATCCAGGTCAGAGCAT-3′ |
Angiotensin receptor 2; SPT | NM_030656 | 5′-GGCTACAGCACATCTGCACAA-3′ | 5′-CCGGGTCCTTCACAAAGAAC-3′ |
Angiotensin/vasopressin receptor | M85183 | 5′-CCGGACACTCGGAGGTTAGTC-3′ | 5′-GGCCCAGAAAGGGAGGTATT-3′ |
Angiotensinogen | NM_134432 | 5′-CCCTGGCTTCCCGTCACT-3′ | 5′-AGTTAGCGCCATCTCCAAGGA-3′ |
Apoptotic protease-activating factor 1; APAF1 | AF320222 | 5′-ACACACTAGACAAGCCCTCTACCA-3′ | 5′-GGGAATATCTAATCTGAAATCCACCTA-3′ |
Bradykinin receptor B1 | NM_030851 | 5′-TCGCCAACTTCTTTGCCTTT-3′ | 5′-CGGCCTGCGAAGACATAAA-3′ |
Caveolin | NM_031556 | 5′-CAGACGAGGTGAATGAGAAGCA-3′ | 5′-TCGCGGTTGACCAGATCAA-3′ |
Dopamine β-hydroxylase | NM_013158 | 5′-GCCGGCCCCTTCGTT-3′ | 5′-CGAGGAGAGGCTGAAGAACAA-3′ |
Dopamine receptor D 1A | NM_012546 | 5′-CCGATAGCTGGGCTCATCA-3′ | 5′-CCTTAAGCAGCCGACTTGGT-3′ |
Dopamine receptor D 2 | NM_012547 | 5′-TGCCTGTGCCGGATCAG-3′ | 5′-CGTGTTCCCTGCTTTCCTATG-3′ |
Dopamine receptor D 4 | NM_012944 | 5′-GCTATGTCAACAGTGCCCTCAA-3′ | 5′-TTGCGGAAGACACTTCGAAA-3′ |
Dopamine receptor D 5 | NM_012768 | 5′-CCGGAGTCGTGGAGCCTAT-3′ | 5′-ACCTTGGTCTCCTTCTTGATGGA-3′ |
Dopamine receptor D 3 | NM_017140 | 5′-TGCTGGCTGCCCTTCTTC-3′ | 5′-GGGACACGTGGCATGCTT-3′ |
Dual endothelin 1, angiotensin II receptor | NM_001004448 | GCGGGTGCTGCATCCA-3′ | 5′-ATCTCCTTGCTCCCCAAAGAG-3′ |
Endothelin 1 | NM_012548 | 5′-CGAGCCCTATGGCCAACTC-3′ | 5′-GCCGGACAGATGTTCTTGCT-3′ |
Endothelin 2 | NM_012549 | 5′-CTGATGGGTTCAGCACAAGCT-3′ | 5′-AGGGTAGCCCTGGCAGTGA-3′ |
Endothelin 3 | XM_345480 | 5′-TTCCAGAAAGTTCCCAGTCTTCTC-3′ | 5′-TGCGCAGGCCTTGTCAT-3′ |
Endothelin-converting enzyme 1 | NM_053596 | 5′-TTTGAGAAGGGCAGAATTAGGAA-3′ | 5′-GGAAACTCCGGGCTTGAGA-3′ |
Endothelin receptor type B | NM_017333 | 5′-AACCGTGCTTGCGGAAAG-3′ | 5′-TGGAAAGTTAGAACGGTTAAAAAACA-3′ |
Erythropoietin receptor | NM_017002 | 5′-CTGGTATTGGATGAATGGTTGCT-3′ | 5′-CCCAGGCCCAGAGAGGTT-3′ |
Nitric oxide synthase 2, inducible | NM_012611 | 5′-CGGGATGTGGCTACCACTTT-3′ | 5′-TCAACCTGCTCCTCACTCAAGTT-3′ |
Nitric oxide synthase 3, endothelial | NM_021838 | 5′-TCATTAGGTTGACCAAGGCAAA-3′ | 5′-GGCAGCCTCGCAACTGA-3′ |
